
Sunshine Biopharma Inc (NASDAQ:SBFM) shares are trading significantly higher Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.
Toxicity studies using non-transformed human cells showed that these mRNA molecules had little or no cytotoxic effects. Sunshine Biopharma said these new mRNA molecules are readily adaptable for delivery into patients using the mRNA vaccine technology. The company expects to file a patent application in connection with these results soon.